[go: up one dir, main page]

AR051201A1 - Derivados de triazol, su fabricacion y empleo como agentes farmaceuticos - Google Patents

Derivados de triazol, su fabricacion y empleo como agentes farmaceuticos

Info

Publication number
AR051201A1
AR051201A1 ARP050103897A ARP050103897A AR051201A1 AR 051201 A1 AR051201 A1 AR 051201A1 AR P050103897 A ARP050103897 A AR P050103897A AR P050103897 A ARP050103897 A AR P050103897A AR 051201 A1 AR051201 A1 AR 051201A1
Authority
AR
Argentina
Prior art keywords
alkyl
manufacture
derivatives
triazol
employment
Prior art date
Application number
ARP050103897A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR051201A1 publication Critical patent/AR051201A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de triazol, preparacion de los compuestos, medicamentos que los contienen y su fabricacion, así como también el empleo de los compuestos mencionados más arriba en el control o prevencion de enfermedades tales como el cáncer. Reivindicacion 1: Un compuesto de formula (1) en donde R1 es -O-alquilo o; -S-alquilo; estando todos los grupos alquilo opcionalmente substituidos una o varias veces con halogeno; R2 es H o halogeno; R3 es H, alquilo o halogeno; W es -C(O)- , -CH(OH)- o -C(alquil)(OH)-, y sales farmacéuticamente aceptables de los mismos.
ARP050103897A 2004-09-21 2005-09-19 Derivados de triazol, su fabricacion y empleo como agentes farmaceuticos AR051201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04022371 2004-09-21

Publications (1)

Publication Number Publication Date
AR051201A1 true AR051201A1 (es) 2006-12-27

Family

ID=34926628

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103897A AR051201A1 (es) 2004-09-21 2005-09-19 Derivados de triazol, su fabricacion y empleo como agentes farmaceuticos

Country Status (8)

Country Link
US (1) US7288557B2 (es)
EP (1) EP1794153A1 (es)
JP (1) JP2008513402A (es)
CN (1) CN101014593A (es)
AR (1) AR051201A1 (es)
CA (1) CA2579408A1 (es)
TW (1) TW200626590A (es)
WO (1) WO2006032453A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200531688A (en) * 2004-03-05 2005-10-01 Hoffmann La Roche Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69736642T2 (de) 1996-07-19 2007-09-20 Takeda Pharmaceutical Co. Ltd. Heterocyclische Verbindungen, ihre Herstellung und Verwendung
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
EP1439178A4 (en) 2001-10-05 2005-11-16 Takeda Pharmaceutical Heterocyclic compounds, oxazole derivatives, process for their preparation and their use
WO2003059907A1 (en) 2002-01-17 2003-07-24 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
JP2003277379A (ja) * 2002-01-17 2003-10-02 Takeda Chem Ind Ltd 含窒素複素環化合物、その製造法および用途

Also Published As

Publication number Publication date
JP2008513402A (ja) 2008-05-01
US7288557B2 (en) 2007-10-30
WO2006032453A1 (en) 2006-03-30
EP1794153A1 (en) 2007-06-13
TW200626590A (en) 2006-08-01
CN101014593A (zh) 2007-08-08
CA2579408A1 (en) 2006-03-30
US20060211750A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
WO2004069803A3 (en) Mono-acylated o-phenylendiamines derivatives and their use against cancer
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
ATE437872T1 (de) Proteinkinaseinhibitoren
UY27714A1 (es) 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos.
UY27592A1 (es) Nuevo uso
NO20090443L (no) 2-metylmorfolin pyrido-, pyrazo- and pyrimido-pyrimidin derivater
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
PA8557001A1 (es) Nuevos derivados de pirrolidina
NO20053775L (no) Diazepinoindol derivater som kinaseinhibitorer.
UY27654A1 (es) Derivados de dihidrobenzodiazepin-ona iii
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
NO20051263L (no) Ny anvendelse av benzotiazolderivater
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20085087L (no) Nye heterocykliske forbindelser
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2004014389A8 (en) 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones
WO2005000281A3 (en) Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
AR051201A1 (es) Derivados de triazol, su fabricacion y empleo como agentes farmaceuticos
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FB Suspension of granting procedure